US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

For many people suffering from asthma, the winter months and the colder air can trigger asthma symptoms and flare-ups, which ...

Conventionally, inhaled drugs have been used to deliver medicines targeted at the most widespread respiratory diseases – specifically, chronic obstructive pulmonary disease (COPD) and asthma.

The most common form of treatment that doctors prescribe for COPD is inhalation therapy, which includes inhalers and nebulizers. Compared to traditional medication inhalers, a nebulizer can ...

It is estimated that nearly half of all patients with asthma do not have their condition under control, mainly as a result of poor adherence to inhaler therapy, leading to increased symptoms and ...

the RespiRx™, today announced the first patient was dosed in its Phase 1 clinical trial evaluating RespiRx™ Nicotine Inhaler (QN-01) as a smoking cessation therapy in the U.S. Smoking ...

To help with COPD flare-ups, you may consider a medication inhaler, antibiotics, oxygen therapy, and hospital care. Your healthcare team can best advise you on treatment for COPD exacerbations.

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Inhalon Biopharma's inhaled RSV antibody treatment will enter human trials marking a potential breakthrough in respiratory ...